Using SGLT2-inhibitors to treat cardiac patients with diabetes
At our 2018 symposium, "Management of Type 2 Diabetes in Patients with CVD: Focus on Heart Failure," nephrologist and scientist Dr. David Cherney explores the use of SGLT2-inhibitors in cardiovascular…